KEGG   PATHWAY: elk05200
Entry
elk05200                    Pathway                                
Name
Pathways in cancer - Enhydra lutris kenyoni (northern sea otter)
Class
Human Diseases; Cancer: overview
Pathway map
elk05200  Pathways in cancer
elk05200

Organism
Enhydra lutris kenyoni (northern sea otter) [GN:elk]
Gene
111142604  netrin receptor DCC [KO:K06765]
111144607  caspase-3 [KO:K02187] [EC:3.4.22.56]
111154673  caspase-9 isoform X1 [KO:K04399] [EC:3.4.22.62]
111143849  DCC-interacting protein 13-alpha [KO:K08733]
111152800  LOW QUALITY PROTEIN: cadherin-1-like [KO:K05689]
111152817  cadherin-1 isoform X1 [KO:K05689]
111159001  catenin beta-1 [KO:K02105]
111140819  catenin alpha-1 [KO:K05691]
111144805  catenin alpha-3 [KO:K05691]
111148019  catenin alpha-2 isoform X1 [KO:K05691]
111156118  axin-1 isoform X1 [KO:K02157]
111158088  axin-2 isoform X1 [KO:K04385]
111161627  adenomatous polyposis coli protein 2 isoform X1 [KO:K02085]
111148270  adenomatous polyposis coli protein isoform X1 [KO:K02085]
111149921  glycogen synthase kinase-3 beta isoform X1 [KO:K03083] [EC:2.7.11.26]
111141244  transcription factor 7 isoform X1 [KO:K02620]
111148131  transcription factor 7-like 1 isoform X1 [KO:K04490]
111145217  transcription factor 7-like 2 isoform X1 [KO:K04491]
111154120  lymphoid enhancer-binding factor 1 isoform X1 [KO:K04492]
111160341  baculoviral IAP repeat-containing protein 5 [KO:K08731]
111146783  myc proto-oncogene protein [KO:K04377]
111149458  G1/S-specific cyclin-D1 [KO:K04503]
111158015  proto-oncogene Wnt-1 [KO:K03209]
111143458  protein Wnt-2b [KO:K00182]
111152038  protein Wnt-2 [KO:K00182]
111139433  protein Wnt-3a [KO:K00312]
111158156  proto-oncogene Wnt-3 [KO:K00312]
111154909  protein Wnt-4 [KO:K00408]
111159795  protein Wnt-5b [KO:K00444]
111144172  protein Wnt-5a isoform X1 [KO:K00444]
111145739  LOW QUALITY PROTEIN: protein Wnt-6 [KO:K00445]
111157688  protein Wnt-7b isoform X1 [KO:K00572]
111159004  protein Wnt-7a [KO:K00572]
111141267  protein Wnt-8a [KO:K00714]
111145241  protein Wnt-8b [KO:K00714]
111139428  protein Wnt-9a [KO:K01064]
111158202  LOW QUALITY PROTEIN: protein Wnt-9b [KO:K01064]
111157990  protein Wnt-10b [KO:K01357]
111144711  protein Wnt-10a [KO:K01357]
111159478  protein Wnt-11 [KO:K01384]
111152110  protein Wnt-16 [KO:K01558]
111141425  frizzled-7 [KO:K02432]
111147325  frizzled-1 [KO:K02432]
111158141  frizzled-2 [KO:K02235]
111156239  frizzled-3 [KO:K02329]
111154467  frizzled-4 [KO:K02354]
111155536  LOW QUALITY PROTEIN: frizzled-8 [KO:K02375]
111143924  frizzled-5 [KO:K02375]
111146642  frizzled-6 [KO:K02376]
111156537  frizzled-10 [KO:K02842]
111146438  frizzled-9 [KO:K02842]
111142027  low-density lipoprotein receptor-related protein 6 [KO:K03068]
111149489  low-density lipoprotein receptor-related protein 5 [KO:K03068]
111154625  segment polarity protein dishevelled homolog DVL-1 isoform X1 [KO:K02353]
111161117  LOW QUALITY PROTEIN: segment polarity protein dishevelled homolog DVL-2 [KO:K02353]
111148907  LOW QUALITY PROTEIN: segment polarity protein dishevelled homolog DVL-3-like [KO:K02353]
111149303  segment polarity protein dishevelled homolog DVL-3 [KO:K02353]
111145138  proto-oncogene FRAT1 [KO:K03069]
111145112  GSK-3-binding protein FRAT2 [KO:K03096]
111149799  prothrombin isoform X1 [KO:K01313] [EC:3.4.21.5]
111160516  angiotensinogen [KO:K09821]
111148319  proteinase-activated receptor 1 [KO:K03914]
111144372  LOW QUALITY PROTEIN: proteinase-activated receptor 4 [KO:K04236]
111145805  lysophosphatidic acid receptor 1 [KO:K04289]
111144147  lysophosphatidic acid receptor 2 [KO:K04291]
111143684  lysophosphatidic acid receptor 3 [KO:K04294]
111160942  lysophosphatidic acid receptor 4 [KO:K04275]
111159825  lysophosphatidic acid receptor 5 [KO:K08390]
111146912  lysophosphatidic acid receptor 6 [KO:K04273]
111150851  type-1 angiotensin II receptor [KO:K04166]
111146098  guanine nucleotide-binding protein subunit alpha-12 isoform X1 [KO:K04346]
111158131  guanine nucleotide-binding protein subunit alpha-13 isoform X1 [KO:K04639]
111153798  rho guanine nucleotide exchange factor 12 isoform X1 [KO:K07532]
111139050  rho guanine nucleotide exchange factor 11 isoform X1 [KO:K12331]
111139489  rho guanine nucleotide exchange factor 1 isoform X1 [KO:K12330]
111154613  pleckstrin homology domain-containing family G member 5 isoform X1 [KO:K19464]
111144026  transforming protein RhoA isoform X1 [KO:K04513]
111142435  rho-associated protein kinase 1 isoform X1 [KO:K04514] [EC:2.7.11.1]
111154090  rho-associated protein kinase 2 isoform X1 [KO:K17388] [EC:2.7.11.1]
111145109  stromal cell-derived factor 1 isoform X1 [KO:K10031]
111145588  C-X-C chemokine receptor type 4 isoform X1 [KO:K04189]
111155312  guanine nucleotide-binding protein G(i) subunit alpha-1 [KO:K04630]
111143783  guanine nucleotide-binding protein G(i) subunit alpha-2 [KO:K04630]
111143343  guanine nucleotide-binding protein G(k) subunit alpha [KO:K04630]
111162566  prostaglandin E2 receptor EP1 subtype [KO:K04258]
111140622  prostaglandin E2 receptor EP2 subtype [KO:K04259]
111143189  prostaglandin E2 receptor EP3 subtype isoform X1 [KO:K04260]
111140991  prostaglandin E2 receptor EP4 subtype [KO:K04261]
111141614  LOW QUALITY PROTEIN: guanine nucleotide-binding protein G(s) subunit alpha isoforms XLas [KO:K04632]
111141312  neuroendocrine secretory protein 55 [KO:K04632]
111157054  adenylate cyclase type 1 [KO:K08041] [EC:4.6.1.1]
111153427  adenylate cyclase type 2 [KO:K08042] [EC:4.6.1.1]
111154044  adenylate cyclase type 3 isoform X1 [KO:K08043] [EC:4.6.1.1]
111162403  adenylate cyclase type 4 isoform X1 [KO:K08044] [EC:4.6.1.1]
111155044  adenylate cyclase type 5 [KO:K08045] [EC:4.6.1.1]
111157825  adenylate cyclase type 6 [KO:K08046] [EC:4.6.1.1]
111157326  adenylate cyclase type 7 isoform X1 [KO:K08047] [EC:4.6.1.1]
111146667  adenylate cyclase type 8 [KO:K08048] [EC:4.6.1.1]
111156133  adenylate cyclase type 9 [KO:K08049] [EC:4.6.1.1]
111162516  cAMP-dependent protein kinase catalytic subunit alpha isoform X1 [KO:K04345] [EC:2.7.11.11]
111143399  cAMP-dependent protein kinase catalytic subunit beta isoform X1 [KO:K04345] [EC:2.7.11.11]
111154601  guanine nucleotide-binding protein G(I)/G(S)/G(T) subunit beta-1 [KO:K04536]
111145586  guanine nucleotide-binding protein G(I)/G(S)/G(T) subunit beta-2 isoform X1 [KO:K04537]
111159773  guanine nucleotide-binding protein G(I)/G(S)/G(T) subunit beta-3 [KO:K07825]
111148588  guanine nucleotide-binding protein subunit beta-4 [KO:K04538]
111140421  guanine nucleotide-binding protein subunit beta-5 [KO:K04539]
111159618  guanine nucleotide-binding protein G(I)/G(S)/G(O) subunit gamma-2 isoform X1 [KO:K07826]
111149566  guanine nucleotide-binding protein G(I)/G(S)/G(O) subunit gamma-3 [KO:K04540]
111160502  guanine nucleotide-binding protein G(I)/G(S)/G(O) subunit gamma-4 [KO:K04541]
111143000  guanine nucleotide-binding protein G(I)/G(S)/G(O) subunit gamma-5 [KO:K04542]
111161718  guanine nucleotide-binding protein G(I)/G(S)/G(O) subunit gamma-7 [KO:K04543]
111160835  guanine nucleotide-binding protein G(I)/G(S)/G(O) subunit gamma-8 [KO:K04544]
111145828  guanine nucleotide-binding protein G(I)/G(S)/G(O) subunit gamma-10 [KO:K04545]
111147333  guanine nucleotide-binding protein G(I)/G(S)/G(O) subunit gamma-11 [KO:K04546]
111162432  uncharacterized LOC105372280 homolog [KO:K04347]
111142967  guanine nucleotide-binding protein G(I)/G(S)/G(O) subunit gamma-12 [KO:K04347]
111156207  guanine nucleotide-binding protein G(I)/G(S)/G(O) subunit gamma-13 [KO:K04547]
111147281  guanine nucleotide-binding protein G(T) subunit gamma-T1 [KO:K04548]
111151818  guanine nucleotide-binding protein G(I)/G(S)/G(O) subunit gamma-T2 [KO:K04549]
111142203  collagen alpha-3(IV) chain [KO:K06237]
111146901  collagen alpha-1(IV) chain [KO:K06237]
111161271  collagen alpha-5(IV) chain [KO:K06237]
111161277  collagen alpha-6(IV) chain [KO:K06237]
111147037  collagen alpha-2(IV) chain [KO:K06237]
111143029  collagen alpha-4(IV) chain [KO:K06237]
111142456  laminin subunit alpha-1 [KO:K05637]
111147662  laminin subunit alpha-2 [KO:K05637]
111142476  laminin subunit alpha-3 isoform X1 [KO:K06240]
111141516  laminin subunit alpha-5 isoform X1 [KO:K06240]
111158255  laminin subunit alpha-4 isoform X1 [KO:K06241]
111155260  laminin subunit beta-1 isoform X1 [KO:K05636]
111144053  laminin subunit beta-2 isoform X1 [KO:K06243]
111162354  laminin subunit beta-3 [KO:K06244]
111155309  laminin subunit beta-4 [KO:K06245]
111150738  laminin subunit gamma-1 [KO:K05635]
111150870  laminin subunit gamma-2 [KO:K06246]
111145465  laminin subunit gamma-3-like [KO:K06247]
111145932  laminin subunit gamma-3 [KO:K06247]
111143733  fibronectin isoform X1 [KO:K05717]
111141135  integrin alpha-2 [KO:K06481]
111158126  integrin alpha-IIb isoform X1 [KO:K06476]
111151764  integrin alpha-3 [KO:K06482]
111144193  integrin alpha-6 isoform X1 [KO:K06485]
111155043  integrin alpha-V isoform X1 [KO:K06487]
111155558  integrin beta-1 isoform X1 [KO:K05719]
111146744  focal adhesion kinase 1 isoform X1 [KO:K05725] [EC:2.7.10.2]
111155003  LOW QUALITY PROTEIN: phosphatidylinositol 4,5-bisphosphate 3-kinase catalytic subunit beta isoform [KO:K00922] [EC:2.7.1.153]
111147545  phosphatidylinositol 4,5-bisphosphate 3-kinase catalytic subunit alpha isoform [KO:K00922] [EC:2.7.1.153]
111154641  phosphatidylinositol 4,5-bisphosphate 3-kinase catalytic subunit delta isoform isoform X1 [KO:K00922] [EC:2.7.1.153]
111143470  phosphatidylinositol 3-kinase regulatory subunit gamma isoform X1 [KO:K02649]
111155224  phosphatidylinositol 3-kinase regulatory subunit alpha isoform X1 [KO:K02649]
111143790  phosphatidylinositol 3-kinase regulatory subunit beta [KO:K02649]
111144778  phosphatidylinositol 3,4,5-trisphosphate 3-phosphatase and dual-specificity protein phosphatase PTEN [KO:K01110] [EC:3.1.3.16 3.1.3.48 3.1.3.67]
111156657  homeobox protein Nkx-3.1 [KO:K09348]
111161374  RAC-beta serine/threonine-protein kinase [KO:K04456] [EC:2.7.11.1]
111148765  RAC-alpha serine/threonine-protein kinase isoform X1 [KO:K04456] [EC:2.7.11.1]
111150885  RAC-gamma serine/threonine-protein kinase isoform X1 [KO:K04456] [EC:2.7.11.1]
111144921  inhibitor of nuclear factor kappa-B kinase subunit alpha isoform X1 [KO:K04467] [EC:2.7.11.10]
111144397  inhibitor of nuclear factor kappa-B kinase subunit beta isoform X1 [KO:K07209] [EC:2.7.11.10]
111139191  NF-kappa-B essential modulator [KO:K07210]
111140276  NF-kappa-B inhibitor alpha isoform X1 [KO:K04734]
111153611  nuclear factor NF-kappa-B p105 subunit isoform X1 [KO:K02580]
111144738  nuclear factor NF-kappa-B p100 subunit isoform X1 [KO:K04469]
111149956  transcription factor p65 [KO:K04735]
111150791  prostaglandin G/H synthase 2 [KO:K11987] [EC:1.14.99.1]
111151537  nitric oxide synthase, inducible isoform X1 [KO:K13241] [EC:1.14.13.39]
111154217  apoptosis regulator Bcl-2 [KO:K02161]
111153673  baculoviral IAP repeat-containing protein 3-like [KO:K16060]
111153695  baculoviral IAP repeat-containing protein 2 [KO:K16060]
111157209  E3 ubiquitin-protein ligase XIAP [KO:K04725] [EC:2.3.2.27]
111141482  LOW QUALITY PROTEIN: baculoviral IAP repeat-containing protein 7 [KO:K16061]
111141775  bcl-2-like protein 1 [KO:K04570]
111146115  TNF receptor-associated factor 1 [KO:K03172]
111145476  TNF receptor-associated factor 2-like [KO:K03173] [EC:2.3.2.27]
111146100  TNF receptor-associated factor 2 isoform X1 [KO:K03173] [EC:2.3.2.27]
111148495  TNF receptor-associated factor 3 isoform X1 [KO:K03174]
111151781  TNF receptor-associated factor 4 [KO:K09848]
111150675  TNF receptor-associated factor 5 [KO:K09849]
111150027  TNF receptor-associated factor 6 [KO:K03175] [EC:2.3.2.27]
111154883  serine/threonine-protein kinase mTOR [KO:K07203] [EC:2.7.11.1]
111149588  ribosomal protein S6 kinase beta-2 isoform X1 [KO:K04688] [EC:2.7.11.1]
111151757  ribosomal protein S6 kinase beta-1 isoform X1 [KO:K04688] [EC:2.7.11.1]
111149975  bcl2-associated agonist of cell death [KO:K02158]
111158571  LOW QUALITY PROTEIN: forkhead box protein O1 [KO:K07201]
111142120  E3 ubiquitin-protein ligase Mdm2 isoform X1 [KO:K06643] [EC:2.3.2.27]
111161133  cellular tumor antigen p53 [KO:K04451]
111142072  cyclin-dependent kinase inhibitor 1B [KO:K06624]
111142115  cyclin-dependent kinase inhibitor 1B [KO:K06624]
111147618  cyclin-dependent kinase inhibitor 1 [KO:K06625]
111142593  breakpoint cluster region protein isoform X1 [KO:K08878] [EC:2.7.11.1]
111146116  tyrosine-protein kinase ABL1 isoform X1 [KO:K06619] [EC:2.7.10.2]
111151533  adapter molecule crk isoform X1 [KO:K04438]
111142678  crk-like protein isoform X1 [KO:K04438]
111153838  E3 ubiquitin-protein ligase CBL [KO:K04707] [EC:2.3.2.27]
111151211  signal transducer and activator of transcription 5A [KO:K11223]
111151253  signal transducer and activator of transcription 5B [KO:K11224]
111147734  serine/threonine-protein kinase pim-1 [KO:K04702] [EC:2.7.11.1]
111150449  serine/threonine-protein kinase pim-2 [KO:K08806] [EC:2.7.11.1]
111148821  kininogen-1 isoform X1 [KO:K03898]
111156738  endothelin-1 [KO:K16366]
111148793  B1 bradykinin receptor [KO:K03915]
111148709  B2 bradykinin receptor [KO:K03916]
111156746  endothelin-1 receptor [KO:K04197]
111146994  endothelin receptor type B [KO:K04198]
111153498  guanine nucleotide-binding protein G(q) subunit alpha [KO:K04634]
111161857  guanine nucleotide-binding protein subunit alpha-11 [KO:K04635]
111141432  1-phosphatidylinositol 4,5-bisphosphate phosphodiesterase beta-1 [KO:K05858] [EC:3.1.4.11]
111162302  1-phosphatidylinositol 4,5-bisphosphate phosphodiesterase beta-2 isoform X1 [KO:K05858] [EC:3.1.4.11]
111141620  1-phosphatidylinositol 4,5-bisphosphate phosphodiesterase beta-4 isoform X1 [KO:K05858] [EC:3.1.4.11]
111150005  1-phosphatidylinositol 4,5-bisphosphate phosphodiesterase beta-3 isoform X1 [KO:K05858] [EC:3.1.4.11]
111158087  protein kinase C alpha type isoform X1 [KO:K02677] [EC:2.7.11.13]
111162208  protein kinase C beta type isoform X1 [KO:K19662] [EC:2.7.11.13]
111139613  protein kinase C gamma type [KO:K19663] [EC:2.7.11.13]
111154869  interleukin-2 [KO:K05429]
111140799  interleukin-3-like [KO:K04736]
111141099  interleukin-4 [KO:K05430]
111141209  interleukin-5 [KO:K05428]
111147365  interleukin-6 isoform X1 [KO:K05405]
111156814  interleukin-7 isoform X1 [KO:K05431]
111150468  interleukin-12 subunit alpha [KO:K05406]
111141150  interleukin-12 subunit beta [KO:K05425]
111141294  interleukin-13 [KO:K05435]
111149196  interleukin-15 [KO:K05433]
111160242  interleukin-23 subunit alpha [KO:K05426]
111145625  erythropoietin [KO:K05437]
111140482  interferon alpha-1/2-like [KO:K05414]
111159856  interferon alpha-1/2-like [KO:K05414]
111159858  interferon alpha-1/2-like [KO:K05414]
111159859  interferon alpha-1/2-like [KO:K05414]
111159861  interferon alpha-1/2-like [KO:K05414]
111159862  interferon alpha-1/2-like [KO:K05414]
111156578  interferon alpha-2-like [KO:K05414]
111156593  interferon alpha-1/2-like [KO:K05414]
111156594  interferon alpha-1/2-like [KO:K05414]
111156604  interferon alpha-like [KO:K05414]
111140592  interferon alpha-1/2-like [KO:K05414]
111156606  interferon alpha-1/2-like [KO:K05414]
111156609  interferon alpha-1/2-like [KO:K05414]
111140329  interferon alpha-1/2-like [KO:K05414]
111140335  interferon alpha-1/2-like [KO:K05414]
111140336  interferon alpha-1/2-like [KO:K05414]
111142126  interferon gamma [KO:K04687]
111158621  interleukin-2 receptor subunit alpha isoform X1 [KO:K05068]
111157559  interleukin-2 receptor subunit beta isoform X1 [KO:K05069]
111161041  cytokine receptor common subunit gamma [KO:K05070]
111157156  interleukin-3 receptor subunit alpha isoform X1 [KO:K04737]
111162191  interleukin-4 receptor subunit alpha isoform X1 [KO:K05071]
111157480  cytokine receptor common subunit beta isoform X1 [KO:K04738]
111144290  interleukin-5 receptor subunit alpha [KO:K05067]
111138952  interleukin-6 receptor subunit alpha isoform X1 [KO:K05055]
111156948  interleukin-6 receptor subunit beta [KO:K05060]
111141253  interleukin-7 receptor subunit alpha isoform X1 [KO:K05072]
111144102  interleukin-12 receptor subunit beta-1 isoform X1 [KO:K05063]
111143098  interleukin-12 receptor subunit beta-2 isoform X1 [KO:K05064]
111157297  interleukin-13 receptor subunit alpha-1 isoform X1 [KO:K05076]
111158614  interleukin-15 receptor subunit alpha [KO:K05074]
111143244  interleukin-23 receptor [KO:K05065]
111162487  erythropoietin receptor [KO:K05079]
111155707  interferon alpha/beta receptor 1 [KO:K05130]
111155645  interferon alpha/beta receptor 2 isoform X1 [KO:K05131]
111147686  interferon gamma receptor 1 [KO:K05132]
111155682  interferon gamma receptor 2 isoform X1 [KO:K05133]
111158506  echinoderm microtubule-associated protein-like 4 isoform X1 [KO:K15420]
111139287  ALK tyrosine kinase receptor [KO:K05119] [EC:2.7.10.1]
111140724  RAS guanyl-releasing protein 1 isoform X1 [KO:K04350]
111149468  RAS guanyl-releasing protein 2 isoform X1 [KO:K12361]
111158513  ras guanyl-releasing protein 3 isoform X1 [KO:K12362]
111161497  LOW QUALITY PROTEIN: RAS guanyl-releasing protein 4 [KO:K12363]
111142881  tyrosine-protein kinase JAK1 [KO:K11217] [EC:2.7.10.2]
111153517  tyrosine-protein kinase JAK2 [KO:K04447] [EC:2.7.10.2]
111143876  tyrosine-protein kinase JAK3 isoform X1 [KO:K11218] [EC:2.7.10.2]
111151241  signal transducer and activator of transcription 3 isoform X1 [KO:K04692]
111144592  signal transducer and activator of transcription 1-alpha/beta isoform X1 [KO:K11220]
111160141  signal transducer and activator of transcription 2 isoform X1 [KO:K11221]
111141082  signal transducer and activator of transcription 4 [KO:K11222]
111160115  signal transducer and activator of transcription 6 [KO:K11225]
111147726  vascular endothelial growth factor A [KO:K05448]
111149705  vascular endothelial growth factor B isoform X1 [KO:K16858]
111148570  placenta growth factor isoform X1 [KO:K16859]
111157184  vascular endothelial growth factor D [KO:K05449]
111144527  vascular endothelial growth factor C [KO:K05449]
111148116  protransforming growth factor alpha [KO:K08774]
111156359  pro-epidermal growth factor isoform X1 [KO:K04357]
111157042  epidermal growth factor receptor isoform X1 [KO:K04361] [EC:2.7.10.1]
111151268  receptor tyrosine-protein kinase erbB-2 isoform X1 [KO:K05083] [EC:2.7.10.1]
111145884  platelet-derived growth factor subunit A isoform X1 [KO:K04359]
111157534  platelet-derived growth factor subunit B isoform X1 [KO:K17386]
111148924  platelet-derived growth factor receptor alpha isoform X1 [KO:K04363] [EC:2.7.10.1]
111140848  platelet-derived growth factor receptor beta isoform X1 [KO:K05089] [EC:2.7.10.1]
111142293  insulin-like growth factor I [KO:K05459]
111142036  insulin-like growth factor I isoform X1 [KO:K05459]
111150034  insulin-like growth factor II isoform X1 [KO:K13769]
111152643  insulin-like growth factor 1 receptor [KO:K05087] [EC:2.7.10.1]
111142191  kit ligand [KO:K05461]
111148912  mast/stem cell growth factor receptor Kit isoform X1 [KO:K05091] [EC:2.7.10.1]
111160696  fms-related tyrosine kinase 3 ligand isoform X1 [KO:K05454]
111158528  receptor-type tyrosine-protein kinase FLT3 isoform X1 [KO:K05092] [EC:2.7.10.1]
111155271  hepatocyte growth factor isoform X1 [KO:K05460]
111151956  hepatocyte growth factor receptor [KO:K05099] [EC:2.7.10.1]
111156955  fibroblast growth factor 1 isoform X1 [KO:K18496]
111156005  LOW QUALITY PROTEIN: fibroblast growth factor 2 [KO:K18497]
111141219  fibroblast growth factor 18 [KO:K04358]
111144621  fibroblast growth factor 20 [KO:K04358]
111159982  fibroblast growth factor 7 isoform X1 [KO:K04358]
111157192  fibroblast growth factor 17 isoform X1 [KO:K04358]
111159837  fibroblast growth factor 6 [KO:K04358]
111160943  fibroblast growth factor 16 [KO:K04358]
111145249  fibroblast growth factor 8 isoform X1 [KO:K04358]
111149486  fibroblast growth factor 3 [KO:K04358]
111150307  fibroblast growth factor 4 [KO:K04358]
111159933  fibroblast growth factor 9 [KO:K04358]
111149253  fibroblast growth factor 5 isoform X1 [KO:K04358]
111141115  fibroblast growth factor 10 [KO:K04358]
111161630  fibroblast growth factor 22 [KO:K04358]
111149408  fibroblast growth factor 19 [KO:K22603]
111160539  fibroblast growth factor 21 [KO:K22429]
111159771  LOW QUALITY PROTEIN: fibroblast growth factor 23 [KO:K22428]
111144420  fibroblast growth factor receptor 1 isoform X1 [KO:K04362] [EC:2.7.10.1]
111145037  fibroblast growth factor receptor 2-like [KO:K05093] [EC:2.7.10.1]
111144712  fibroblast growth factor receptor 2 isoform X1 [KO:K05093] [EC:2.7.10.1]
111149137  fibroblast growth factor receptor 3 isoform X1 [KO:K05094] [EC:2.7.10.1]
111140867  fibroblast growth factor receptor 4 isoform X1 [KO:K05095] [EC:2.7.10.1]
111160411  growth factor receptor-bound protein 2 [KO:K04364]
111158354  son of sevenless homolog 1 isoform X1 [KO:K03099]
111160889  son of sevenless homolog 2 isoform X1 [KO:K03099]
111140316  GTPase HRas isoform X1 [KO:K02833]
111159984  GTPase KRas isoform X1 [KO:K07827]
111143238  GTPase NRas [KO:K07828]
111150582  serine/threonine-protein kinase A-Raf isoform X1 [KO:K08845] [EC:2.7.11.1]
111151941  serine/threonine-protein kinase B-raf isoform X1 [KO:K04365] [EC:2.7.11.1]
111144322  RAF proto-oncogene serine/threonine-protein kinase isoform X1 [KO:K04366] [EC:2.7.11.1]
111153158  dual specificity mitogen-activated protein kinase kinase 1 [KO:K04368] [EC:2.7.12.2]
111161815  dual specificity mitogen-activated protein kinase kinase 2 [KO:K04369] [EC:2.7.12.2]
111162236  LOW QUALITY PROTEIN: mitogen-activated protein kinase 3 [KO:K04371] [EC:2.7.11.24]
111142759  mitogen-activated protein kinase 1 [KO:K04371] [EC:2.7.11.24]
111143174  transcription factor AP-1 [KO:K04448]
111148602  proto-oncogene c-Fos [KO:K04379]
111154029  protein C-ets-1 isoform X1 [KO:K02678]
111153766  interstitial collagenase [KO:K01388] [EC:3.4.24.7]
111153845  interstitial collagenase-like [KO:K01388] [EC:3.4.24.7]
111157340  72 kDa type IV collagenase [KO:K01398] [EC:3.4.24.24]
111141396  matrix metalloproteinase-9 [KO:K01403] [EC:3.4.24.35]
111149115  interleukin-8 [KO:K10030]
111160230  cyclin-dependent kinase 4 [KO:K02089] [EC:2.7.11.22]
111148567  ribosomal protein S6 kinase alpha-5 isoform X1 [KO:K04445] [EC:2.7.11.1]
111145007  proto-oncogene tyrosine-protein kinase receptor Ret [KO:K05126] [EC:2.7.10.1]
111144710  coiled-coil domain-containing protein 6 [KO:K09288]
111144880  nuclear receptor coactivator 4 isoform X1 [KO:K09289]
111138872  high affinity nerve growth factor receptor isoform X1 [KO:K03176] [EC:2.7.10.1]
111138967  tropomyosin alpha-3 chain isoform X1 [KO:K09290]
111150655  nucleoprotein TPR isoform X1 [KO:K09291]
111147863  protein TFG [KO:K09292]
111143767  ras association domain-containing protein 1 isoform X1 [KO:K09850]
111151024  ras association domain-containing protein 5 isoform X1 [KO:K08015]
111141470  serine/threonine-protein kinase 4 [KO:K04411]
111161839  death-associated protein kinase 3 [KO:K08803] [EC:2.7.11.1]
111153261  death-associated protein kinase 2 isoform X1 [KO:K08803] [EC:2.7.11.1]
111153491  death-associated protein kinase 1 isoform X1 [KO:K08803] [EC:2.7.11.1]
111141423  1-phosphatidylinositol 4,5-bisphosphate phosphodiesterase gamma-1 isoform X1 [KO:K01116] [EC:3.1.4.11]
111152978  1-phosphatidylinositol 4,5-bisphosphate phosphodiesterase gamma-2 isoform X1 [KO:K05859] [EC:3.1.4.11]
111150586  ETS domain-containing protein Elk-1 isoform X1 [KO:K04375]
111158594  calmodulin-like [KO:K02183]
111158606  calmodulin-like protein 3 [KO:K02183]
111154855  calmodulin-like protein 6 [KO:K02183]
111160633  calmodulin-3 [KO:K02183]
111155835  calmodulin-2 [KO:K02183]
111148494  calmodulin-1 isoform X1 [KO:K02183]
111153268  calmodulin-like protein 4 isoform X1 [KO:K02183]
111140840  calcium/calmodulin-dependent protein kinase type II subunit alpha [KO:K04515] [EC:2.7.11.17]
111145432  calcium/calmodulin-dependent protein kinase type II subunit gamma isoform X1 [KO:K04515] [EC:2.7.11.17]
111153485  calcium/calmodulin-dependent protein kinase type II subunit delta isoform X1 [KO:K04515] [EC:2.7.11.17]
111156985  calcium/calmodulin-dependent protein kinase type II subunit beta [KO:K04515] [EC:2.7.11.17]
111145587  ral guanine nucleotide dissociation stimulator isoform X1 [KO:K08732]
111157020  ras-related protein Ral-A [KO:K07834]
111141953  ras-related protein Ral-B [KO:K07835]
111142686  ralA-binding protein 1 [KO:K08773]
111154823  cell division control protein 42 homolog isoform X1 [KO:K04393]
111145636  ras-related C3 botulinum toxin substrate 1 isoform X1 [KO:K04392]
111157484  ras-related C3 botulinum toxin substrate 2 [KO:K07860]
111160304  ras-related C3 botulinum toxin substrate 3 isoform X1 [KO:K07861]
111161193  phospholipase D2 [KO:K01115] [EC:3.1.4.4]
111150121  phospholipase D1 isoform X1 [KO:K01115] [EC:3.1.4.4]
111144860  mitogen-activated protein kinase 8 [KO:K04440] [EC:2.7.11.24]
111158897  mitogen-activated protein kinase 9 isoform X1 [KO:K04440] [EC:2.7.11.24]
111154016  mitogen-activated protein kinase 10 isoform X1 [KO:K04440] [EC:2.7.11.24]
111158488  paired box protein Pax-8 isoform X1 [KO:K09293]
111144031  peroxisome proliferator-activated receptor gamma [KO:K08530]
111146039  retinoic acid receptor RXR-alpha [KO:K08524]
111152195  retinoic acid receptor RXR-beta isoform X1 [KO:K08525]
111151020  retinoic acid receptor RXR-gamma isoform X1 [KO:K08526]
111155167  retinoic acid receptor beta isoform X1 [KO:K08528]
111158708  estrogen receptor isoform X1 [KO:K08550]
111162581  estrogen receptor beta isoform X1 [KO:K08551]
111154077  nuclear receptor coactivator 1 isoform X1 [KO:K09101] [EC:2.3.1.48]
111141850  nuclear receptor coactivator 3 isoform X1 [KO:K11256] [EC:2.3.1.48]
111157856  transcription factor Sp1 isoform X1 [KO:K04684]
111152376  peroxisome proliferator-activated receptor delta [KO:K04504]
111151683  junction plakoglobin [KO:K10056]
111153896  zinc finger and BTB domain-containing protein 16 [KO:K10055]
111151320  retinoic acid receptor alpha isoform X1 [KO:K08527]
111154269  cyclin-A2 [KO:K06627]
111158563  cyclin-A1 [KO:K06627]
111153323  protein PML isoform X1 [KO:K10054] [EC:2.3.2.-]
111155817  runt-related transcription factor 1 isoform X1 [KO:K08367]
111146561  protein CBFA2T1 isoform X1 [KO:K10053]
111149957  transcription factor PU.1 isoform X1 [KO:K09438]
111161485  CCAAT/enhancer-binding protein alpha [KO:K09055]
111157141  granulocyte-macrophage colony-stimulating factor receptor subunit alpha isoform X1 [KO:K05066]
111157114  granulocyte-macrophage colony-stimulating factor receptor subunit alpha-like [KO:K05066]
111143352  granulocyte colony-stimulating factor receptor [KO:K05061]
111140850  LOW QUALITY PROTEIN: macrophage colony-stimulating factor 1 receptor [KO:K05090] [EC:2.7.10.1]
111159871  cyclin-dependent kinase inhibitor 2A-like isoform X1 [KO:K06621]
111141556  transcription factor E2F1 [KO:K17454]
111154729  transcription factor E2F2 isoform X1 [KO:K09389]
111138625  transcription factor E2F3 isoform X1 [KO:K06620]
111161903  protein max isoform X1 [KO:K04453]
111154581  zinc finger and BTB domain-containing protein 17 isoform X1 [KO:K10500]
111159872  cyclin-dependent kinase 4 inhibitor B [KO:K04685]
111147246  cyclin-dependent kinase 6 [KO:K02091] [EC:2.7.11.22]
111159766  G1/S-specific cyclin-D2 [KO:K10151]
111147855  G1/S-specific cyclin-D3 isoform X1 [KO:K10152]
111138867  cyclin-dependent kinases regulatory subunit 1 [KO:K02219]
111153573  cyclin-dependent kinases regulatory subunit 2 [KO:K02219]
111141245  S-phase kinase-associated protein 1 isoform X1 [KO:K03094]
111154336  cullin-1 [KO:K03347]
111157501  E3 ubiquitin-protein ligase RBX1 isoform X1 [KO:K03868] [EC:2.3.2.32]
111140933  S-phase kinase-associated protein 2 [KO:K03875]
111160135  cyclin-dependent kinase 2 isoform X1 [KO:K02206] [EC:2.7.11.22]
111161443  G1/S-specific cyclin-E1 isoform X1 [KO:K06626]
111146791  G1/S-specific cyclin-E2 [KO:K06626]
111146911  retinoblastoma-associated protein [KO:K06618]
111143201  growth arrest and DNA damage-inducible protein GADD45 alpha isoform X1 [KO:K04402]
111161789  growth arrest and DNA damage-inducible protein GADD45 beta [KO:K04402]
111153625  growth arrest and DNA damage-inducible protein GADD45 gamma [KO:K04402]
111160657  apoptosis regulator BAX isoform X1 [KO:K02159]
111152355  bcl-2 homologous antagonist/killer [KO:K14021]
111150113  DNA damage-binding protein 2 isoform X1 [KO:K10140]
111148313  DNA polymerase kappa [KO:K03511] [EC:2.7.7.7]
111153386  telomerase reverse transcriptase isoform X1 [KO:K11126] [EC:2.7.7.49]
111143979  microphthalmia-associated transcription factor isoform X1 [KO:K09455]
111161420  transforming growth factor beta-1 isoform X1 [KO:K13375]
111151068  transforming growth factor beta-2 isoform X1 [KO:K13376]
111148592  transforming growth factor beta-3 [KO:K13377]
111146071  TGF-beta receptor type-1 isoform X1 [KO:K04674] [EC:2.7.11.30]
111158999  TGF-beta receptor type-2 [KO:K04388] [EC:2.7.11.30]
111142395  mothers against decapentaplegic homolog 2 isoform X1 [KO:K04500]
111153179  mothers against decapentaplegic homolog 3 [KO:K23605]
111142438  mothers against decapentaplegic homolog 4 [KO:K04501]
111148284  MDS1 and EVI1 complex locus protein EVI1 isoform X1 [KO:K04462] [EC:2.1.1.367]
111145392  C-terminal-binding protein 2 isoform X1 [KO:K04496] [EC:1.1.1.428]
111149368  C-terminal-binding protein 1 isoform X1 [KO:K04496] [EC:1.1.1.428]
111142974  histone deacetylase 1 isoform X1 [KO:K06067] [EC:3.5.1.98]
111158262  histone deacetylase 2 isoform X1 [KO:K06067] [EC:3.5.1.98]
111159091  DNA mismatch repair protein Mlh1 isoform X1 [KO:K08734]
111148098  DNA mismatch repair protein Msh2 [KO:K08735]
111148257  LOW QUALITY PROTEIN: DNA mismatch repair protein Msh3 [KO:K08736]
111148106  DNA mismatch repair protein Msh6 isoform X1 [KO:K08737]
111158584  breast cancer type 2 susceptibility protein [KO:K08775]
111159884  DNA repair protein RAD51 homolog 1 [KO:K04482]
111150819  tumor necrosis factor ligand superfamily member 6-like [KO:K04389]
111150909  tumor necrosis factor ligand superfamily member 6 [KO:K04389]
111144883  tumor necrosis factor receptor superfamily member 6 [KO:K04390]
111149616  FAS-associated death domain protein [KO:K02373]
111141026  caspase-8 isoform X1 [KO:K04398] [EC:3.4.22.61]
111159768  BH3-interacting domain death agonist [KO:K04726]
111154272  phorbol-12-myristate-13-acetate-induced protein 1 [KO:K10131]
111160670  LOW QUALITY PROTEIN: bcl-2-binding component 3 [KO:K10132]
111158508  bcl-2-like protein 11 isoform X1 [KO:K16341]
111147305  cytochrome c isoform X1 [KO:K08738]
111142635  LOW QUALITY PROTEIN: cytochrome c, testis-specific-like [KO:K08738]
111141900  LOW QUALITY PROTEIN: uncharacterized protein LOC111141900 [KO:K08738]
111142091  apoptotic protease-activating factor 1 isoform X1 [KO:K02084]
111145267  caspase-7 isoform X1 [KO:K04397] [EC:3.4.22.60]
111162515  kelch-like ECH-associated protein 1 [KO:K10456]
111142427  nuclear factor erythroid 2-related factor 2 isoform X1 [KO:K05638]
111157602  heme oxygenase 1 [KO:K00510] [EC:1.14.14.18]
111152948  NAD(P)H dehydrogenase [quinone] 1 [KO:K00355] [EC:1.6.5.2]
111142465  glutathione S-transferase theta-3-like isoform X1 [KO:K00799] [EC:2.5.1.18]
111142466  LOW QUALITY PROTEIN: glutathione S-transferase theta-1-like [KO:K00799] [EC:2.5.1.18]
111145156  microsomal glutathione S-transferase 3 [KO:K00799] [EC:2.5.1.18]
111145196  glutathione S-transferase omega-2 [KO:K00799] [EC:2.5.1.18]
111142554  glutathione S-transferase theta-1-like [KO:K00799] [EC:2.5.1.18]
111152231  glutathione S-transferase A1 isoform X1 [KO:K00799] [EC:2.5.1.18]
111143242  glutathione S-transferase Mu 1 isoform X1 [KO:K00799] [EC:2.5.1.18]
111144914  glutathione S-transferase omega-1 [KO:K00799] [EC:2.5.1.18]
111152273  glutathione S-transferase A4 [KO:K00799] [EC:2.5.1.18]
111152274  glutathione S-transferase A4-like [KO:K00799] [EC:2.5.1.18]
111152337  glutathione S-transferase-like [KO:K00799] [EC:2.5.1.18]
111142607  glutathione S-transferase theta-2B [KO:K00799] [EC:2.5.1.18]
111142618  glutathione S-transferase theta-4 [KO:K00799] [EC:2.5.1.18]
111142156  microsomal glutathione S-transferase 1 [KO:K00799] [EC:2.5.1.18]
111149277  microsomal glutathione S-transferase 2 isoform X1 [KO:K00799] [EC:2.5.1.18]
111151007  microsomal glutathione S-transferase 3 [KO:K00799] [EC:2.5.1.18]
111143069  glutathione S-transferase Mu 3 isoform X1 [KO:K00799] [EC:2.5.1.18]
111149481  glutathione S-transferase P [KO:K23790] [EC:2.5.1.18]
111149482  glutathione S-transferase P-like [KO:K23790] [EC:2.5.1.18]
111142082  thioredoxin reductase 1, cytoplasmic [KO:K22182] [EC:1.8.1.9]
111142575  thioredoxin reductase 2, mitochondrial isoform X1 [KO:K22182] [EC:1.8.1.9]
111159006  thioredoxin reductase 3 [KO:K22182] [EC:1.8.1.9]
111144039  von Hippel-Lindau disease tumor suppressor isoform X1 [KO:K03871]
111156807  elongin-C [KO:K03872]
111156112  elongin-B [KO:K03873]
111155593  cullin-2 isoform X1 [KO:K03870]
111160932  egl nine homolog 3 isoform X1 [KO:K09592] [EC:1.14.11.29]
111161431  egl nine homolog 2 [KO:K09592] [EC:1.14.11.29]
111160510  egl nine homolog 1 isoform X1 [KO:K09592] [EC:1.14.11.29]
111150761  fumarate hydratase, mitochondrial [KO:K01679] [EC:4.2.1.2]
111159390  hypoxia-inducible factor 1-alpha isoform X1 [KO:K08268]
111155870  endothelial PAS domain-containing protein 1 [KO:K09095]
111161943  aryl hydrocarbon receptor nuclear translocator isoform X1 [KO:K09097]
111152532  aryl hydrocarbon receptor nuclear translocator 2 isoform X1 [KO:K15589]
111157665  histone acetyltransferase p300 [KO:K04498] [EC:2.3.1.48]
111156131  LOW QUALITY PROTEIN: CREB-binding protein [KO:K04498] [EC:2.3.1.48]
111143335  solute carrier family 2, facilitated glucose transporter member 1 isoform X1 [KO:K07299]
111141735  LOW QUALITY PROTEIN: protein jagged-1 [KO:K06052]
111148619  protein jagged-2 [KO:K21635]
111161598  delta-like protein 3 isoform X1 [KO:K06051]
111158683  delta-like protein 1 isoform X1 [KO:K06051]
111161567  delta-like protein 4 [KO:K06051]
111145671  neurogenic locus notch homolog protein 1 [KO:K02599]
111142867  neurogenic locus notch homolog protein 2 [KO:K20994]
111143932  neurogenic locus notch homolog protein 3 [KO:K20995]
111152233  neurogenic locus notch homolog protein 4 isoform X1 [KO:K20996]
111155108  transcription factor HES-1 [KO:K06054]
111154575  transcription factor HES-5 [KO:K06055]
111156810  hairy/enhancer-of-split related with YRPW motif protein 1 isoform X1 [KO:K09091]
111143160  hairy/enhancer-of-split related with YRPW motif-like protein [KO:K09091]
111147815  hairy/enhancer-of-split related with YRPW motif protein 2 [KO:K09091]
111158898  vascular endothelial growth factor receptor 3 isoform X1 [KO:K05097] [EC:2.7.10.1]
111154521  sonic hedgehog protein [KO:K11988]
111139086  LOW QUALITY PROTEIN: protein patched homolog 1 [KO:K06225]
111152017  smoothened homolog [KO:K06226]
111152688  kinesin-like protein KIF7 [KO:K18806]
111145420  suppressor of fused homolog isoform X1 [KO:K06229]
111160237  zinc finger protein GLI1 isoform X1 [KO:K16797]
111144403  zinc finger protein GLI2 [KO:K16798]
111157049  transcriptional activator GLI3 [KO:K06230]
111141639  LOW QUALITY PROTEIN: bone morphogenetic protein 2 [KO:K21283]
111162047  bone morphogenetic protein 4 isoform X1 [KO:K04662]
111156387  hedgehog-interacting protein [KO:K06231]
111143114  LOW QUALITY PROTEIN: protein patched homolog 2 [KO:K11101]
111161016  androgen receptor [KO:K08557]
111147500  heat shock protein HSP 90-beta [KO:K04079]
111148518  heat shock protein HSP 90-alpha [KO:K04079]
111142066  endoplasmin isoform X1 [KO:K09487]
Compound
C00027  Hydrogen peroxide
C00039  DNA
C00076  Calcium cation
C00122  Fumarate
C00149  (S)-Malate
C00165  Diacylglycerol
C00187  Cholesterol
C00280  Androstenedione
C00410  Progesterone
C00416  Phosphatidate
C00533  Nitric oxide
C00535  Testosterone
C00575  3',5'-Cyclic AMP
C00584  Prostaglandin E2
C00681  1-Acyl-sn-glycerol 3-phosphate
C00704  Superoxide
C00735  Cortisol
C00762  Cortisone
C00777  Retinoate
C00951  Estradiol-17beta
C01227  Dehydroepiandrosterone
C01245  D-myo-Inositol 1,4,5-trisphosphate
C01471  Acrolein
C03917  Dihydrotestosterone
C05981  Phosphatidylinositol-3,4,5-trisphosphate
C07653  Flutamide
C15493  9-cis-Retinoic acid
C16038  2-Amino-1-methyl-6-phenylimidazo[4,5-b]pyridine
C16844  Hydroxyl radical
C21641  Hydroperoxyl radical
C21642  4-Hydroxynonenal
Reference
  Authors
Weinberg RA.
  Title
The biology of cancer
  Journal
Garland Science, Taylor & Francis Group, LLC (2007)
Reference
  Authors
Hanahan D, Weinberg RA
  Title
The hallmarks of cancer.
  Journal
Cell 100:57-70 (2000)
DOI:10.1016/S0092-8674(00)81683-9
Reference
  Authors
Grady WM.
  Title
Genomic instability and colon cancer.
  Journal
Cancer Metastasis Rev 23:11-27 (2004)
DOI:10.1023/A:1025861527711
Reference
  Authors
Soreide K, Janssen EA, Soiland H, Korner H, Baak JP.
  Title
Microsatellite instability in colorectal cancer.
  Journal
Br J Surg 93:395-406 (2006)
DOI:10.1002/bjs.5328
Reference
  Authors
Anwar S, Hall C, White J, Deakin M, Farrell W, Elder JB.
  Title
Hereditary non-polyposis colorectal cancer: an updated review.
  Journal
Eur J Surg Oncol 26:635-45 (2000)
DOI:10.1053/ejso.2000.0974
Reference
  Authors
Takayama T, Miyanishi K, Hayashi T, Sato Y, Niitsu Y.
  Title
Colorectal cancer: genetics of development and metastasis.
  Journal
J Gastroenterol 41:185-92 (2006)
DOI:10.1007/s00535-006-1801-6
Reference
  Authors
Lynch HT, de la Chapelle A.
  Title
Hereditary colorectal cancer.
  Journal
N Engl J Med 348:919-32 (2003)
DOI:10.1056/NEJMra012242
Reference
  Authors
Rajagopalan H, Nowak MA, Vogelstein B, Lengauer C.
  Title
The significance of unstable chromosomes in colorectal cancer.
  Journal
Nat Rev Cancer 3:695-701 (2003)
DOI:10.1038/nrc1165
Reference
  Authors
Behrens J.
  Title
Cadherins and catenins: role in signal transduction and tumor progression.
  Journal
Cancer Metastasis Rev 18:15-30 (1999)
DOI:10.1023/A:1006200102166
Reference
  Authors
Behrens J.
  Title
The role of the Wnt signalling pathway in colorectal tumorigenesis.
  Journal
Biochem Soc Trans 33:672-5 (2005)
DOI:10.1042/BST0330672
Reference
  Authors
Behrens J, Lustig B.
  Title
The Wnt connection to tumorigenesis.
  Journal
Int J Dev Biol 48:477-87 (2004)
DOI:10.1387/ijdb.041815jb
Reference
PMID:9196022
  Authors
Polakis P.
  Title
The adenomatous polyposis coli (APC) tumor suppressor.
  Journal
Biochim Biophys Acta 1332:F127-47 (1997)
DOI:10.1016/S0304-419X(97)00008-5
Reference
  Authors
Janssen KP.
  Title
Murine models of colorectal cancer: studying the role of oncogenic K-ras.
  Journal
Cell Mol Life Sci 60:495-506 (2003)
DOI:10.1007/s000180300041
Reference
  Authors
Adjei AA.
  Title
Blocking oncogenic Ras signaling for cancer therapy.
  Journal
J Natl Cancer Inst 93:1062-74 (2001)
DOI:10.1093/jnci/93.14.1062
Reference
  Authors
Arakawa H.
  Title
Netrin-1 and its receptors in tumorigenesis.
  Journal
Nat Rev Cancer 4:978-87 (2004)
DOI:10.1038/nrc1504
Reference
  Authors
Mehlen P, Fearon ER.
  Title
Role of the dependence receptor DCC in colorectal cancer pathogenesis.
  Journal
J Clin Oncol 22:3420-8 (2004)
DOI:10.1200/JCO.2004.02.019
Reference
  Authors
Peltomaki P.
  Title
DNA mismatch repair and cancer.
  Journal
Mutat Res 488:77-85 (2001)
DOI:10.1016/S1383-5742(00)00058-2
Reference
  Authors
Li F, Cao Y, Townsend CM Jr, Ko TC.
  Title
TGF-beta signaling in colon cancer cells.
  Journal
World J Surg 29:306-11 (2005)
DOI:10.1007/s00268-004-7813-6
Reference
  Authors
Roman C, Saha D, Beauchamp R.
  Title
TGF-beta and colorectal carcinogenesis.
  Journal
Reference
  Authors
Watson AJ.
  Title
An overview of apoptosis and the prevention of colorectal cancer.
  Journal
Crit Rev Oncol Hematol 57:107-21 (2006)
DOI:10.1016/j.critrevonc.2005.06.005
Reference
  Authors
Watson AJ.
  Title
Apoptosis and colorectal cancer.
  Journal
Gut 53:1701-9 (2004)
DOI:10.1136/gut.2004.052704
Reference
  Authors
Houlston RS.
  Title
What we could do now: molecular pathology of colorectal cancer.
  Journal
Mol Pathol 54:206-14 (2001)
DOI:10.1136/mp.54.4.206
Reference
  Authors
Von Hoff D, Evans D, Hruban R (ed).
  Title
Pancreatic cancer
  Journal
Jones and Bartlett publishers (2005)
Reference
  Authors
Niitsu Y, Yokota J (ed).
  Title
[Oncogenes and Tumor Suppressor Genes for Medical Oncologist] (In Japanese)
  Journal
Nankodo (1999)
Reference
  Authors
Bardeesy N, DePinho RA.
  Title
Pancreatic cancer biology and genetics.
  Journal
Nat Rev Cancer 2:897-909 (2002)
DOI:10.1038/nrc949
Reference
  Authors
Bardeesy N, Sharpless NE, DePinho RA, Merlino G.
  Title
The genetics of pancreatic adenocarcinoma: a roadmap for a mouse model.
  Journal
Semin Cancer Biol 11:201-18 (2001)
DOI:10.1006/scbi.2000.0371
Reference
  Authors
Cowgill SM, Muscarella P.
  Title
The genetics of pancreatic cancer.
  Journal
Am J Surg 186:279-86 (2003)
DOI:10.1016/S0002-9610(03)00226-5
Reference
  Authors
Hezel AF, Kimmelman AC, Stanger BZ, Bardeesy N, Depinho RA.
  Title
Genetics and biology of pancreatic ductal adenocarcinoma.
  Journal
Genes Dev 20:1218-49 (2006)
DOI:10.1101/gad.1415606
Reference
  Authors
Shields JM, Pruitt K, McFall A, Shaub A, Der CJ.
  Title
Understanding Ras: 'it ain't over 'til it's over'.
  Journal
Trends Cell Biol 10:147-54 (2000)
DOI:10.1016/S0962-8924(00)01740-2
Reference
  Authors
Holbro T, Civenni G, Hynes NE.
  Title
The ErbB receptors and their role in cancer progression.
  Journal
Exp Cell Res 284:99-110 (2003)
DOI:10.1016/S0014-4827(02)00099-X
Reference
  Authors
Marmor MD, Skaria KB, Yarden Y.
  Title
Signal transduction and oncogenesis by ErbB/HER receptors.
  Journal
Int J Radiat Oncol Biol Phys 58:903-13 (2004)
DOI:10.1016/j.ijrobp.2003.06.002
Reference
  Authors
DeArmond D, Brattain MG, Jessup JM, Kreisberg J, Malik S, Zhao S, Freeman JW.
  Title
Autocrine-mediated ErbB-2 kinase activation of STAT3 is required for growth factor independence of pancreatic cancer cell lines.
  Journal
Oncogene 22:7781-95 (2003)
DOI:10.1038/sj.onc.1206966
Reference
  Authors
Wei D, Le X, Zheng L, Wang L, Frey JA, Gao AC, Peng Z, Huang S, Xiong HQ, Abbruzzese JL, Xie K.
  Title
Stat3 activation regulates the expression of vascular endothelial growth factor and human pancreatic cancer angiogenesis and metastasis.
  Journal
Oncogene 22:319-29 (2003)
DOI:10.1038/sj.onc.1206122
Reference
  Authors
Toyonaga T, Nakano K, Nagano M, Zhao G, Yamaguchi K, Kuroki S, Eguchi T, Chijiiwa K, Tsuneyoshi M, Tanaka M.
  Title
Blockade of constitutively activated Janus kinase/signal transducer and activator of transcription-3 pathway inhibits growth of human pancreatic cancer.
  Journal
Cancer Lett 201:107-16 (2003)
DOI:10.1016/S0304-3835(03)00482-8
Reference
  Authors
Schmid RM.
  Title
Genetic basis of pancreatic cancer.
  Journal
Best Pract Res Clin Gastroenterol 16:421-33 (2002)
DOI:10.1053/bega.2002.0316
Reference
  Authors
Elliott RL, Blobe GC.
  Title
Role of transforming growth factor Beta in human cancer.
  Journal
J Clin Oncol 23:2078-93 (2005)
DOI:10.1200/JCO.2005.02.047
Reference
  Authors
Rudkin TM, Foulkes WD.
  Title
BRCA2: breaks, mistakes and failed separations.
  Journal
Trends Mol Med 11:145-8 (2005)
DOI:10.1016/j.molmed.2005.02.003
Reference
  Authors
Venkitaraman AR.
  Title
Functions of BRCA1 and BRCA2 in the biological response to DNA damage.
  Journal
J Cell Sci 114:3591-8 (2001)
Reference
  Authors
Soni D, King JA, Kaye AH, Hovens CM.
  Title
Genetics of glioblastoma multiforme: mitogenic signaling and cell cycle pathways converge.
  Journal
J Clin Neurosci 12:1-5 (2005)
DOI:10.1016/j.jocn.2004.04.001
Reference
  Authors
Zhu Y, Parada LF.
  Title
The molecular and genetic basis of neurological tumours.
  Journal
Nat Rev Cancer 2:616-26 (2002)
DOI:10.1038/nrc866
Reference
  Authors
Holland EC.
  Title
Gliomagenesis: genetic alterations and mouse models.
  Journal
Nat Rev Genet 2:120-9 (2001)
DOI:10.1038/35052535
Reference
  Authors
Bansal K, Liang ML, Rutka JT.
  Title
Molecular biology of human gliomas.
  Journal
Technol Cancer Res Treat 5:185-94 (2006)
DOI:10.1177/153303460600500302
Reference
  Authors
Tabuchi K (ed).
  Title
[Gliomas: Research and therapy] (In Japanese)
  Journal
Springer-Verlag Tokyo (2006)
Reference
  Authors
Kapoor GS, O'Rourke DM.
  Title
Mitogenic signaling cascades in glial tumors.
  Journal
Neurosurgery 52:1425-34; discussion 1434-5 (2003)
DOI:10.1227/01.NEU.0000065135.28143.39
Reference
  Authors
Hulleman E, Helin K.
  Title
Molecular mechanisms in gliomagenesis.
  Journal
Adv Cancer Res 94:1-27 (2005)
DOI:10.1016/S0065-230X(05)94001-3
Reference
  Authors
Schlessinger J.
  Title
Cell signaling by receptor tyrosine kinases.
  Journal
Cell 103:211-25 (2000)
DOI:10.1016/S0092-8674(00)00114-8
Reference
PMID:9643506
  Authors
Ng HK, Lam PY.
  Title
The molecular genetics of central nervous system tumors.
  Journal
Pathology 30:196-202 (1998)
DOI:10.1080/00313029800169236
Reference
  Authors
Knobbe CB, Merlo A, Reifenberger G.
  Title
Pten signaling in gliomas.
  Journal
Neuro-oncol 4:196-211 (2002)
DOI:10.1093/neuonc/4.3.196
Reference
  Authors
Kondo T, Ezzat S, Asa SL.
  Title
Pathogenetic mechanisms in thyroid follicular-cell neoplasia.
  Journal
Nat Rev Cancer 6:292-306 (2006)
DOI:10.1038/nrc1836
Reference
  Authors
Chiloeches A, Marais R.
  Title
Is BRAF the Achilles' Heel of thyroid cancer?
  Journal
Clin Cancer Res 12:1661-4 (2006)
DOI:10.1158/1078-0432.CCR-06-0051
Reference
  Authors
Reddi HV, McIver B, Grebe SK, Eberhardt NL
  Title
The paired box-8/peroxisome proliferator-activated receptor-gamma oncogene in thyroid tumorigenesis.
  Journal
Endocrinology 148:932-5 (2007)
DOI:10.1210/en.2006-0926
Reference
  Authors
Santoro M, Melillo RM, Fusco A.
  Title
RET/PTC activation in papillary thyroid carcinoma: European Journal of Endocrinology Prize Lecture.
  Journal
Eur J Endocrinol 155:645-653 (2006)
DOI:10.1530/eje.1.02289
Reference
  Authors
Pierotti MA, Greco A.
  Title
Oncogenic rearrangements of the NTRK1/NGF receptor.
  Journal
Cancer Lett 232:90-8 (2006)
DOI:10.1016/j.canlet.2005.07.043
Reference
  Authors
Sobrinho-Simoes M, Preto A, Rocha AS, Castro P, Maximo V, Fonseca E, Soares P.
  Title
Molecular pathology of well-differentiated thyroid carcinomas.
  Journal
Virchows Arch 447:787-93 (2005)
DOI:10.1007/s00428-005-0065-5
Reference
  Authors
Gimm O.
  Title
Thyroid cancer.
  Journal
Cancer Lett 163:143-56 (2001)
DOI:10.1016/S0304-3835(00)00697-2
Reference
  Authors
Williams D.
  Title
Cancer after nuclear fallout: lessons from the Chernobyl accident.
  Journal
Nat Rev Cancer 2:543-9 (2002)
DOI:10.1038/nrc845
Reference
  Authors
Steffen B, Muller-Tidow C, Schwable J, Berdel WE, Serve H.
  Title
The molecular pathogenesis of acute myeloid leukemia.
  Journal
Crit Rev Oncol Hematol 56:195-221 (2005)
DOI:10.1016/j.critrevonc.2004.10.012
Reference
  Authors
Tenen DG.
  Title
Disruption of differentiation in human cancer: AML shows the way.
  Journal
Nat Rev Cancer 3:89-101 (2003)
DOI:10.1038/nrc989
Reference
  Authors
Choudhary C, Muller-Tidow C, Berdel WE, Serve H.
  Title
Signal transduction of oncogenic Flt3.
  Journal
Int J Hematol 82:93-9 (2005)
DOI:10.1532/IJH97.05090
Reference
  Authors
Stirewalt DL, Radich JP.
  Title
The role of FLT3 in haematopoietic malignancies.
  Journal
Nat Rev Cancer 3:650-65 (2003)
DOI:10.1038/nrc1169
Reference
  Authors
Martelli AM, Nyakern M, Tabellini G, Bortul R, Tazzari PL, Evangelisti C, Cocco L.
  Title
Phosphoinositide 3-kinase/Akt signaling pathway and its therapeutical implications for human acute myeloid leukemia.
  Journal
Leukemia 20:911-28 (2006)
DOI:10.1038/sj.leu.2404245
Reference
  Authors
Lennartsson J, Jelacic T, Linnekin D, Shivakrupa R.
  Title
Normal and oncogenic forms of the receptor tyrosine kinase kit.
  Journal
Stem Cells 23:16-43 (2005)
DOI:10.1634/stemcells.2004-0117
Reference
  Authors
Lorsbach RB, Downing JR.
  Title
The role of the AML1 transcription factor in leukemogenesis.
  Journal
Int J Hematol 74:258-65 (2001)
DOI:10.1007/BF02982058
Reference
  Authors
Mizuki M, Schwable J, Steur C, Choudhary C, Agrawal S, Sargin B, Steffen B, Matsumura I, Kanakura Y, Bohmer FD, Muller-Tidow C, Berdel WE, Serve H.
  Title
Suppression of myeloid transcription factors and induction of STAT response genes by AML-specific Flt3 mutations.
  Journal
Blood 101:3164-73 (2003)
DOI:10.1182/blood-2002-06-1677
Reference
  Authors
Mikesch JH, Steffen B, Berdel WE, Serve H, Muller-Tidow C.
  Title
The emerging role of Wnt signaling in the pathogenesis of acute myeloid leukemia.
  Journal
Leukemia 21:1638-47 (2007)
DOI:10.1038/sj.leu.2404732
Reference
  Authors
Mueller BU, Pabst T, Fos J, Petkovic V, Fey MF, Asou N, Buergi U, Tenen DG.
  Title
ATRA resolves the differentiation block in t(15;17) acute myeloid leukemia by restoring PU.1 expression.
  Journal
Blood 107:3330-8 (2006)
DOI:10.1182/blood-2005-07-3068
Reference
  Authors
Ren R.
  Title
Mechanisms of BCR-ABL in the pathogenesis of chronic myelogenous leukaemia.
  Journal
Nat Rev Cancer 5:172-83 (2005)
DOI:10.1038/nrc1567
Reference
  Authors
Deininger MW, Goldman JM, Melo JV.
  Title
The molecular biology of chronic myeloid leukemia.
  Journal
Blood 96:3343-56 (2000)
Reference
  Authors
Calabretta B, Perrotti D.
  Title
The biology of CML blast crisis.
  Journal
Blood 103:4010-22 (2004)
DOI:10.1182/blood-2003-12-4111
Reference
  Authors
Faderl S, Talpaz M, Estrov Z, O'Brien S, Kurzrock R, Kantarjian HM.
  Title
The biology of chronic myeloid leukemia.
  Journal
N Engl J Med 341:164-72 (1999)
DOI:10.1056/NEJM199907153410306
Reference
  Authors
Mitani K.
  Title
Molecular mechanisms of leukemogenesis by AML1/EVI-1.
  Journal
Oncogene 23:4263-9 (2004)
DOI:10.1038/sj.onc.1207777
Reference
  Authors
Dong M, Blobe GC.
  Title
Role of transforming growth factor-beta in hematologic malignancies.
  Journal
Blood 107:4589-96 (2006)
DOI:10.1182/blood-2005-10-4169
Reference
PMID:9834202
  Authors
Kurokawa M, Mitani K, Imai Y, Ogawa S, Yazaki Y, Hirai H.
  Title
The t(3;21) fusion product, AML1/Evi-1, interacts with Smad3 and blocks transforming growth factor-beta-mediated growth inhibition of myeloid cells.
  Journal
Blood 92:4003-12 (1998)
Reference
  Authors
Brusa G, Benvenuti M, Mazzacurati L, Mancini M, Pattacini L, Martinelli G, Barbieri E, Greenberger JS, Baccarani M, Santucci MA.
  Title
p53 loss of function enhances genomic instability and accelerates clonal evolution of murine myeloid progenitors expressing the p(210)BCR-ABL tyrosine kinase.
  Journal
Haematologica 88:622-30 (2003)
Reference
  Authors
Baldwin AS.
  Title
Control of oncogenesis and cancer therapy resistance by the transcription factor NF-kappaB.
  Journal
J Clin Invest 107:241-6 (2001)
DOI:10.1172/JCI11991
Reference
  Authors
Shin I, Yakes FM, Rojo F, Shin NY, Bakin AV, Baselga J, Arteaga CL.
  Title
PKB/Akt mediates cell-cycle progression by phosphorylation of p27(Kip1) at threonine 157 and modulation of its cellular localization.
  Journal
Nat Med 8:1145-52 (2002)
DOI:10.1038/nm759
Reference
  Authors
Tilli CM, Van Steensel MA, Krekels GA, Neumann HA, Ramaekers FC.
  Title
Molecular aetiology and pathogenesis of basal cell carcinoma.
  Journal
Br J Dermatol 152:1108-24 (2005)
DOI:10.1111/j.1365-2133.2005.06587.x
Reference
  Authors
Saldanha G, Fletcher A, Slater DN.
  Title
Basal cell carcinoma: a dermatopathological and molecular biological update.
  Journal
Br J Dermatol 148:195-202 (2003)
DOI:10.1046/j.1365-2133.2003.05151.x
Reference
  Authors
Daya-Grosjean L, Couve-Privat S.
  Title
Sonic hedgehog signaling in basal cell carcinomas.
  Journal
Cancer Lett 225:181-92 (2005)
DOI:10.1016/j.canlet.2004.10.003
Reference
  Authors
Tsai KY, Tsao H.
  Title
The genetics of skin cancer.
  Journal
Am J Med Genet C Semin Med Genet 131C:82-92 (2004)
DOI:10.1002/ajmg.c.30037
Reference
  Authors
Athar M, Tang X, Lee JL, Kopelovich L, Kim AL.
  Title
Hedgehog signalling in skin development and cancer.
  Journal
Exp Dermatol 15:667-77 (2006)
DOI:10.1111/j.1600-0625.2006.00473.x
Reference
  Authors
Rubin AI, Chen EH, Ratner D.
  Title
Basal-cell carcinoma.
  Journal
N Engl J Med 353:2262-9 (2005)
DOI:10.1056/NEJMra044151
Reference
  Authors
Saldanha G.
  Title
The Hedgehog signalling pathway and cancer.
  Journal
Reference
  Authors
Saldanha G, Ghura V, Potter L, Fletcher A.
  Title
Nuclear beta-catenin in basal cell carcinoma correlates with increased proliferation.
  Journal
Br J Dermatol 151:157-64 (2004)
DOI:10.1111/j.1365-2133.2004.06048.x
Reference
  Authors
Pasca di Magliano M, Hebrok M.
  Title
Hedgehog signalling in cancer formation and maintenance.
  Journal
Nat Rev Cancer 3:903-11 (2003)
DOI:10.1038/nrc1229
Reference
  Authors
Reifenberger J, Wolter M, Knobbe CB, Kohler B, Schonicke A, Scharwachter C, Kumar K, Blaschke B, Ruzicka T, Reifenberger G.
  Title
Somatic mutations in the PTCH, SMOH, SUFUH and TP53 genes in sporadic basal cell carcinomas.
  Journal
Br J Dermatol 152:43-51 (2005)
DOI:10.1111/j.1365-2133.2005.06353.x
Reference
  Authors
Cohen MM Jr.
  Title
The hedgehog signaling network.
  Journal
Am J Med Genet A 123:5-28 (2003)
DOI:10.1002/ajmg.a.20495
Reference
  Authors
Yamazaki F, Aragane Y, Kawada A, Tezuka T.
  Title
Immunohistochemical detection for nuclear beta-catenin in sporadic basal cell carcinoma.
  Journal
Br J Dermatol 145:771-7 (2001)
DOI:10.1046/j.1365-2133.2001.04468.x
Reference
  Authors
Erb P, Ji J, Wernli M, Kump E, Glaser A, Buchner SA.
  Title
Role of apoptosis in basal cell and squamous cell carcinoma formation.
  Journal
Immunol Lett 100:68-72 (2005)
DOI:10.1016/j.imlet.2005.06.008
Reference
  Authors
Toftgard R.
  Title
Hedgehog signalling in cancer.
  Journal
Cell Mol Life Sci 57:1720-31 (2000)
DOI:10.1007/PL00000654
Reference
  Authors
Miller AJ, Mihm MC Jr.
  Title
Melanoma.
  Journal
N Engl J Med 355:51-65 (2006)
DOI:10.1056/NEJMra052166
Reference
  Authors
Chin L.
  Title
The genetics of malignant melanoma: lessons from mouse and man.
  Journal
Nat Rev Cancer 3:559-70 (2003)
DOI:10.1038/nrc1145
Reference
  Authors
Takata M, Saida T.
  Title
Genetic alterations in melanocytic tumors.
  Journal
J Dermatol Sci 43:1-10 (2006)
DOI:10.1016/j.jdermsci.2006.05.002
Reference
  Authors
Chudnovsky Y, Khavari PA, Adams AE.
  Title
Melanoma genetics and the development of rational therapeutics.
  Journal
J Clin Invest 115:813-24 (2005)
DOI:10.1172/JCI24808
Reference
  Authors
Merlino G.
  Title
Cancer biology: the weakest link?
  Journal
Nature 436:33-5 (2005)
DOI:10.1038/436033a
Reference
  Authors
Garraway LA, Widlund HR, Rubin MA, Getz G, Berger AJ, Ramaswamy S, Beroukhim R, Milner DA, Granter SR, Du J, Lee C, Wagner SN, Li C, Golub TR, Rimm DL, Meyerson ML, Fisher DE, Sellers WR.
  Title
Integrative genomic analyses identify MITF as a lineage survival oncogene amplified in malignant melanoma.
  Journal
Nature 436:117-22 (2005)
DOI:10.1038/nature03664
Reference
  Authors
Levy C, Khaled M, Fisher DE.
  Title
MITF: master regulator of melanocyte development and melanoma oncogene.
  Journal
Trends Mol Med 12:406-14 (2006)
DOI:10.1016/j.molmed.2006.07.008
Reference
  Authors
Tsao H, Goel V, Wu H, Yang G, Haluska FG.
  Title
Genetic interaction between NRAS and BRAF mutations and PTEN/MMAC1 inactivation in melanoma.
  Journal
J Invest Dermatol 122:337-41 (2004)
DOI:10.1046/j.0022-202X.2004.22243.x
Reference
  Authors
Gruss C, Herlyn M.
  Title
Role of cadherins and matrixins in melanoma.
  Journal
Curr Opin Oncol 13:117-23 (2001)
DOI:10.1097/00001622-200103000-00006
Reference
  Authors
Thompson JF, Scolyer RA, Kefford RF.
  Title
Cutaneous melanoma.
  Journal
Lancet 365:687-701 (2005)
DOI:10.1016/S0140-6736(05)17951-3
Reference
  Authors
Omholt K, Platz A, Kanter L, Ringborg U, Hansson J.
  Title
NRAS and BRAF mutations arise early during melanoma pathogenesis and are preserved throughout tumor progression.
  Journal
Clin Cancer Res 9:6483-8 (2003)
Reference
  Authors
Hussein MR.
  Title
The TP53 tumor suppressor gene and melanoma tumorigenesis: is there a relationship?
  Journal
Tumour Biol 25:200-7 (2004)
DOI:10.1159/000081103
Reference
  Authors
Lazar-Molnar E, Hegyesi H, Toth S, Falus A.
  Title
Autocrine and paracrine regulation by cytokines and growth factors in melanoma.
  Journal
Cytokine 12:547-54 (2000)
DOI:10.1006/cyto.1999.0614
Reference
  Authors
Cohen HT, McGovern FJ.
  Title
Renal-cell carcinoma.
  Journal
N Engl J Med 353:2477-90 (2005)
DOI:10.1056/NEJMra043172
Reference
  Authors
Pavlovich CP, Schmidt LS.
  Title
Searching for the hereditary causes of renal-cell carcinoma.
  Journal
Nat Rev Cancer 4:381-93 (2004)
DOI:10.1038/nrc1364
Reference
  Authors
Linehan WM, Walther MM, Zbar B.
  Title
The genetic basis of cancer of the kidney.
  Journal
J Urol 170:2163-72 (2003)
DOI:10.1097/01.ju.0000096060.92397.ed
Reference
  Authors
Birchmeier C, Birchmeier W, Gherardi E, Vande Woude GF.
  Title
Met, metastasis, motility and more.
  Journal
Nat Rev Mol Cell Biol 4:915-25 (2003)
DOI:10.1038/nrm1261
Reference
  Authors
Kim WY, Kaelin WG.
  Title
Role of VHL gene mutation in human cancer.
  Journal
J Clin Oncol 22:4991-5004 (2004)
DOI:10.1200/JCO.2004.05.061
Reference
  Authors
Sudarshan S, Linehan WM, Neckers L.
  Title
HIF and fumarate hydratase in renal cancer.
  Journal
Br J Cancer 96:403-7 (2007)
DOI:10.1038/sj.bjc.6603547
Reference
  Authors
Sudarshan S, Pinto PA, Neckers L, Linehan WM.
  Title
Mechanisms of disease: hereditary leiomyomatosis and renal cell cancer--a distinct form of hereditary kidney cancer.
  Journal
Nat Clin Pract Urol 4:104-10 (2007)
DOI:10.1038/ncpuro0711
Reference
  Authors
Bodmer D, van den Hurk W, van Groningen JJ, Eleveld MJ, Martens GJ, Weterman MA, van Kessel AG.
  Title
Understanding familial and non-familial renal cell cancer.
  Journal
Hum Mol Genet 11:2489-98 (2002)
DOI:10.1093/hmg/11.20.2489
Reference
  Authors
Mitra AP, Datar RH, Cote RJ.
  Title
Molecular pathways in invasive bladder cancer: new insights into mechanisms, progression, and target identification.
  Journal
J Clin Oncol 24:5552-64 (2006)
DOI:10.1200/JCO.2006.08.2073
Reference
  Authors
Wolff EM, Liang G, Jones PA.
  Title
Mechanisms of Disease: genetic and epigenetic alterations that drive bladder cancer.
  Journal
Nat Clin Pract Urol 2:502-10 (2005)
DOI:10.1038/ncpuro0318
Reference
  Authors
Wu XR.
  Title
Urothelial tumorigenesis: a tale of divergent pathways.
  Journal
Nat Rev Cancer 5:713-25 (2005)
DOI:10.1038/nrc1697
Reference
  Authors
Brown NS, Jones A, Fujiyama C, Harris AL, Bicknell R.
  Title
Thymidine phosphorylase induces carcinoma cell oxidative stress and promotes secretion of angiogenic factors.
  Journal
Cancer Res 60:6298-302 (2000)
Reference
  Authors
Bellmunt J, Hussain M, Dinney CP.
  Title
Novel approaches with targeted therapies in bladder cancer. Therapy of bladder cancer by blockade of the epidermal growth factor receptor family.
  Journal
Crit Rev Oncol Hematol 46 Suppl:S85-104 (2003)
DOI:10.1016/S1040-8428(03)00067-2
Reference
  Authors
Sugano K, Kakizoe T.
  Title
Genetic alterations in bladder cancer and their clinical applications in molecular tumor staging.
  Journal
Nat Clin Pract Urol 3:642-52 (2006)
DOI:10.1038/ncpuro0649
Reference
  Authors
Dunn KL, Espino PS, Drobic B, He S, Davie JR.
  Title
The Ras-MAPK signal transduction pathway, cancer and chromatin remodeling.
  Journal
Biochem Cell Biol 83:1-14 (2005)
DOI:10.1139/o04-121
Reference
  Authors
Williams SG, Stein JP.
  Title
Molecular pathways in bladder cancer.
  Journal
Urol Res 32:373-85 (2004)
DOI:10.1007/s00240-003-0345-y
Reference
  Authors
Nelson WG, De Marzo AM, Isaacs WB.
  Title
Prostate cancer.
  Journal
N Engl J Med 349:366-81 (2003)
DOI:10.1056/NEJMra021562
Reference
  Authors
Li L, Ittmann MM, Ayala G, Tsai MJ, Amato RJ, Wheeler TM, Miles BJ, Kadmon D, Thompson TC.
  Title
The emerging role of the PI3-K-Akt pathway in prostate cancer progression.
  Journal
Prostate Cancer Prostatic Dis 8:108-18 (2005)
DOI:10.1038/sj.pcan.4500776
Reference
  Authors
Pienta KJ, Bradley D.
  Title
Mechanisms underlying the development of androgen-independent prostate cancer.
  Journal
Clin Cancer Res 12:1665-71 (2006)
DOI:10.1158/1078-0432.CCR-06-0067
Reference
  Authors
Feldman BJ, Feldman D.
  Title
The development of androgen-independent prostate cancer.
  Journal
Nat Rev Cancer 1:34-45 (2001)
DOI:10.1038/35094009
Reference
  Authors
Heinlein CA, Chang C.
  Title
Androgen receptor in prostate cancer.
  Journal
Endocr Rev 25:276-308 (2004)
DOI:10.1210/er.2002-0032
Reference
PMID:9422516
  Authors
Koivisto P, Kolmer M, Visakorpi T, Kallioniemi OP.
  Title
Androgen receptor gene and hormonal therapy failure of prostate cancer.
  Journal
Am J Pathol 152:1-9 (1998)
Reference
  Authors
Zhao XY, Malloy PJ, Krishnan AV, Swami S, Navone NM, Peehl DM, Feldman D.
  Title
Glucocorticoids can promote androgen-independent growth of prostate cancer cells through a mutated androgen receptor.
  Journal
Nat Med 6:703-6 (2000)
DOI:10.1038/76287
Reference
  Authors
Macri E, Loda M.
  Title
Role of p27 in prostate carcinogenesis.
  Journal
Cancer Metastasis Rev 17:337-44 (1998)
DOI:10.1023/A:1006133620914
Reference
  Authors
Steers WD.
  Title
5alpha-reductase activity in the prostate.
  Journal
Urology 58:17-24; discussion 24 (2001)
DOI:10.1016/S0090-4295(01)01299-7
Reference
PMID:8069858
  Authors
Lin D, Meyer DJ, Ketterer B, Lang NP, Kadlubar FF.
  Title
Effects of human and rat glutathione S-transferases on the covalent DNA binding of the N-acetoxy derivatives of heterocyclic amine carcinogens in vitro: a possible mechanism of organ specificity in their carcinogenesis.
  Journal
Cancer Res 54:4920-6 (1994)
Reference
  Authors
Grimes CA, Jope RS.
  Title
The multifaceted roles of glycogen synthase kinase 3beta in cellular signaling.
  Journal
Prog Neurobiol 65:391-426 (2001)
DOI:10.1016/S0301-0082(01)00011-9
Reference
  Authors
Ryan AJ, Susil B, Jobling TW, Oehler MK.
  Title
Endometrial cancer.
  Journal
Cell Tissue Res 322:53-61 (2005)
DOI:10.1007/s00441-005-1109-5
Reference
  Authors
Lax SF.
  Title
Molecular genetic pathways in various types of endometrial carcinoma: from a phenotypical to a molecular-based classification.
  Journal
Virchows Arch 444:213-23 (2004)
DOI:10.1007/s00428-003-0947-3
Reference
  Authors
Shiozawa T, Konishi I.
  Title
Early endometrial carcinoma: clinicopathology, hormonal aspects, molecular genetics, diagnosis, and treatment.
  Journal
Int J Clin Oncol 11:13-21 (2006)
DOI:10.1007/s10147-005-0546-1
Reference
  Authors
Hecht JL, Mutter GL.
  Title
Molecular and pathologic aspects of endometrial carcinogenesis.
  Journal
J Clin Oncol 24:4783-91 (2006)
DOI:10.1200/JCO.2006.06.7173
Reference
  Authors
Matias-Guiu X, Catasus L, Bussaglia E, Lagarda H, Garcia A, Pons C, Munoz J, Arguelles R, Machin P, Prat J.
  Title
Molecular pathology of endometrial hyperplasia and carcinoma.
  Journal
Hum Pathol 32:569-77 (2001)
DOI:10.1053/hupa.2001.25929
Reference
  Authors
Slomovitz BM, Broaddus RR, Burke TW, Sneige N, Soliman PT, Wu W, Sun CC, Munsell MF, Gershenson DM, Lu KH.
  Title
Her-2/neu overexpression and amplification in uterine papillary serous carcinoma.
  Journal
J Clin Oncol 22:3126-32 (2004)
DOI:10.1200/JCO.2004.11.154
Reference
PMID:7585656
  Authors
Saffari B, Jones LA, el-Naggar A, Felix JC, George J, Press MF.
  Title
Amplification and overexpression of HER-2/neu (c-erbB2) in endometrial cancers: correlation with overall survival.
  Journal
Cancer Res 55:5693-8 (1995)
Reference
  Authors
Kim D, Chung J.
  Title
Akt: versatile mediator of cell survival and beyond.
  Journal
J Biochem Mol Biol 35:106-15 (2002)
DOI:10.5483/bmbrep.2002.35.1.106
Reference
  Authors
Sanchez-Cespedes M.
  Title
Dissecting the genetic alterations involved in lung carcinogenesis.
  Journal
Lung Cancer 40:111-21 (2003)
DOI:10.1016/S0169-5002(03)00033-3
Reference
  Authors
Kaye FJ.
  Title
Molecular biology of lung cancer.
  Journal
Lung Cancer 34 Suppl 2:S35-41 (2001)
DOI:10.1016/S0169-5002(01)00342-7
Reference
  Authors
Shivapurkar N, Reddy J, Chaudhary PM, Gazdar AF.
  Title
Apoptosis and lung cancer: a review.
  Journal
J Cell Biochem 88:885-98 (2003)
DOI:10.1002/jcb.10440
Reference
  Authors
Sartorius UA, Krammer PH.
  Title
Upregulation of Bcl-2 is involved in the mediation of chemotherapy resistance in human small cell lung cancer cell lines.
  Journal
Int J Cancer 97:584-92 (2002)
DOI:10.1002/ijc.10096
Reference
  Authors
Adhikary S, Eilers M.
  Title
Transcriptional regulation and transformation by Myc proteins.
  Journal
Nat Rev Mol Cell Biol 6:635-45 (2005)
DOI:10.1038/nrm1703
Reference
  Authors
Spruck C, Strohmaier H, Watson M, Smith AP, Ryan A, Krek TW, Reed SI.
  Title
A CDK-independent function of mammalian Cks1: targeting of SCF(Skp2) to the CDK inhibitor p27Kip1.
  Journal
Mol Cell 7:639-50 (2001)
DOI:10.1016/S1097-2765(01)00210-6
Reference
  Authors
Buttery RC, Rintoul RC, Sethi T.
  Title
Small cell lung cancer: the importance of the extracellular matrix.
  Journal
Int J Biochem Cell Biol 36:1154-60 (2004)
DOI:10.1016/S1357-2725(03)00261-9
Reference
  Authors
Yamada KM, Araki M.
  Title
Tumor suppressor PTEN: modulator of cell signaling, growth, migration and apoptosis.
  Journal
J Cell Sci 114:2375-82 (2001)
Reference
  Authors
Rintoul RC, Sethi T.
  Title
The role of extracellular matrix in small-cell lung cancer.
  Journal
Lancet Oncol 2:437-42 (2001)
DOI:10.1016/S1470-2045(00)00421-6
Reference
  Authors
Ekedahl J, Joseph B, Grigoriev MY, Muller M, Magnusson C, Lewensohn R, Zhivotovsky B.
  Title
Expression of inhibitor of apoptosis proteins in small- and non-small-cell lung carcinoma cells.
  Journal
Exp Cell Res 279:277-90 (2002)
DOI:10.1006/excr.2002.5608
Reference
  Authors
Osada H, Takahashi T.
  Title
Genetic alterations of multiple tumor suppressors and oncogenes in the carcinogenesis and progression of lung cancer.
  Journal
Oncogene 21:7421-34 (2002)
DOI:10.1038/sj.onc.1205802
Reference
  Authors
Yokota J, Nishioka M, Tani M, Kohno T.
  Title
Genetic alterations responsible for metastatic phenotypes of lung cancer cells.
  Journal
Clin Exp Metastasis 20:189-93 (2003)
DOI:10.1023/a:1022978932215
Reference
  Authors
Aviel-Ronen S, Blackhall FH, Shepherd FA, Tsao MS.
  Title
K-ras mutations in non-small-cell lung carcinoma: a review.
  Journal
Clin Lung Cancer 8:30-8 (2006)
DOI:10.3816/CLC.2006.n.030
Reference
  Authors
Pfeifer GP, Dammann R.
  Title
Methylation of the tumor suppressor gene RASSF1A in human tumors.
  Journal
Biochemistry (Mosc) 70:576-83 (2005)
DOI:10.1007/s10541-005-0151-y
Reference
  Authors
Altucci L, Gronemeyer H.
  Title
The promise of retinoids to fight against cancer.
  Journal
Nat Rev Cancer 1:181-93 (2001)
DOI:10.1038/35106036
Reference
  Authors
Virmani AK, Rathi A, Zochbauer-Muller S, Sacchi N, Fukuyama Y, Bryant D, Maitra A, Heda S, Fong KM, Thunnissen F, Minna JD, Gazdar AF.
  Title
Promoter methylation and silencing of the retinoic acid receptor-beta gene in lung carcinomas.
  Journal
J Natl Cancer Inst 92:1303-7 (2000)
DOI:10.1093/jnci/92.16.1303
Reference
  Authors
Hirsch FR, Scagliotti GV, Langer CJ, Varella-Garcia M, Franklin WA.
  Title
Epidermal growth factor family of receptors in preneoplasia and lung cancer: perspectives for targeted therapies.
  Journal
Lung Cancer 41 Suppl 1:S29-42 (2003)
DOI:10.1016/S0169-5002(03)00137-5
Reference
  Authors
Panani AD, Roussos C.
  Title
Cytogenetic and molecular aspects of lung cancer.
  Journal
Cancer Lett 239:1-9 (2006)
DOI:10.1016/j.canlet.2005.06.030
Reference
  Authors
Mitsuuchi Y, Testa JR.
  Title
Cytogenetics and molecular genetics of lung cancer.
  Journal
Am J Med Genet 115:183-8 (2002)
DOI:10.1002/ajmg.10692
Reference
  Authors
Breuer RH, Postmus PE, Smit EF.
  Title
Molecular pathology of non-small-cell lung cancer.
  Journal
Respiration 72:313-30 (2005)
DOI:10.1159/000085376
Reference
  Authors
Piyathilake CJ, Frost AR, Manne U, Weiss H, Bell WC, Heimburger DC, Grizzle WE.
  Title
Differential expression of growth factors in squamous cell carcinoma and precancerous lesions of the lung.
  Journal
Clin Cancer Res 8:734-44 (2002)
Reference
  Authors
Awaya H, Takeshima Y, Furonaka O, Kohno N, Inai K.
  Title
Gene amplification and protein expression of EGFR and HER2 by chromogenic in situ hybridisation and immunohistochemistry in atypical adenomatous hyperplasia and adenocarcinoma of the lung.
  Journal
J Clin Pathol 58:1076-80 (2005)
DOI:10.1136/jcp.2004.025585
Reference
  Authors
Lappano R, Maggiolini M
  Title
G protein-coupled receptors: novel targets for drug discovery in cancer.
  Journal
Nat Rev Drug Discov 10:47-60 (2011)
DOI:10.1038/nrd3320
Reference
  Authors
O'Hayre M, Degese MS, Gutkind JS
  Title
Novel insights into G protein and G protein-coupled receptor signaling in cancer.
  Journal
Curr Opin Cell Biol 27:126-35 (2014)
DOI:10.1016/j.ceb.2014.01.005
Reference
  Authors
Dorsam RT, Gutkind JS
  Title
G-protein-coupled receptors and cancer.
  Journal
Nat Rev Cancer 7:79-94 (2007)
DOI:10.1038/nrc2069
Related
pathway
elk03320  PPAR signaling pathway
elk04010  MAPK signaling pathway
elk04020  Calcium signaling pathway
elk04024  cAMP signaling pathway
elk04060  Cytokine-cytokine receptor interaction
elk04066  HIF-1 signaling pathway
elk04110  Cell cycle
elk04115  p53 signaling pathway
elk04150  mTOR signaling pathway
elk04151  PI3K-Akt signaling pathway
elk04210  Apoptosis
elk04310  Wnt signaling pathway
elk04330  Notch signaling pathway
elk04340  Hedgehog signaling pathway
elk04350  TGF-beta signaling pathway
elk04370  VEGF signaling pathway
elk04510  Focal adhesion
elk04512  ECM-receptor interaction
elk04520  Adherens junction
elk04630  JAK-STAT signaling pathway
elk04915  Estrogen signaling pathway
KO pathway
ko05200   
LinkDB

DBGET integrated database retrieval system